<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2024-21-3-01</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-2634</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>Особенности липидного метаболизма при синдроме полиорганной недостаточности: причины и следствия возникших изменений обмена</article-title><trans-title-group xml:lang="en"><trans-title>Features of lipid metabolism in multiple organ dysfunction syndrome: causes and consequences of the resulting metabolic changes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8836-8990</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осипенко</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Osipenko</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Осипенко Александр Николаевич, старший преподаватель кафедры естествознания,</p><p>Могилев</p></bio><bio xml:lang="en"><p>Alexander N. Osipenko, Senior Lecturer, Department of Natural Sciences,</p><p>Mogilev</p></bio><email xlink:type="simple">alosipenko@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1659-5902</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Точило</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tachyla</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Точило Сергей Анатольевич, к.м.н., доцент, врач анестезиолог-реаниматолог отделения анестезиологии и реанимации;</p><p>заведующий филиалом кафедр анестезиологии и реаниматологии с курсом ФПК и ПК и госпитальной хирургии с курсом ФПК и ПК</p><p>Могилев</p></bio><bio xml:lang="en"><p>Siarhei A. Tachyla, Candidate of Medical Sciences, Associate Professor, Anesthesiologist-Reanimatologist at the Department of Anesthesiology and Intensive Care;</p><p>Head of the branch of Departments of Anesthesiology and Intensive Care with the course of Advanced Training and Retraining and the Department of Hospital Surgery with the course of Advanced Training and Retraining,</p><p>Vitebsk</p></bio><email xlink:type="simple">tsa80@inbox.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5092-8315</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Марочков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Marochkov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Марочков Алексей Викторович, д.м.н., профессор, врач анестезиолог-реаниматолог отделения анестезиологии и реанимации;</p><p>профессор филиала кафедр анестезиологии и реаниматологии с курсом ФПК и ПК и госпитальной хирургиис курсом ФПК и ПК,</p><p>Могилев</p></bio><bio xml:lang="en"><p>Alexey V. Marochkov, Doctor of Medical Sciences, Professor, Anesthesiologist-Reanimatologist at the Department ofAnesthesiology and Intensive Care;</p><p>Professor of the branch of Departments of Anesthesiology and Intensive Care with the course of Advanced Trainingand Retraining and the Department of Hospital Surgery with the course of Advanced Training and Retraining,</p><p>Vitebsk</p></bio><email xlink:type="simple">marochkov@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Могилевский государственный университет имени А.А, Кулешова</institution></aff><aff xml:lang="en"><institution>Mogilev State A. Kuleshov University</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Могилевская областная клиническая больница&#13;
Витебский государственный ордена Дружбы народов медицинский университет</institution></aff><aff xml:lang="en"><institution>Mogilev Regional Clinical Hospital;&#13;
Vitebsk State Order of Peoples’ Friendship Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>28</day><month>05</month><year>2024</year></pub-date><volume>21</volume><issue>3</issue><fpage>7</fpage><lpage>16</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Осипенко А.Н., Точило С.А., Марочков А.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Осипенко А.Н., Точило С.А., Марочков А.В.</copyright-holder><copyright-holder xml:lang="en">Osipenko A.N., Tachyla S.A., Marochkov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/2634">https://journal.gsmu.by/jour/article/view/2634</self-uri><abstract><p>В обзоре представлены данные различных исследователей, в том числе и авторов данной статьи, касающиеся роли нарушения обмена липидов, а также причин, их вызвавших, в формировании синдрома полиорганной недостаточности (СПОН). Приводятся сведения о вкладе интенсивного липолиза в жировых депо в развитие иммунного ответа, а также в формирование острого респираторного дистресс-синдрома (ОРДС) и острого повреждения почек. Характеризуется вклад интенсивного липолиза в процесс изменения состава жирных кислот плазмы крови. Показано значение интенсификации окислительного метаболизма арахидоновой кислоты крови в развитии расстройств кровообращения и возникновении системного воспаления. Описано изменение липидного метаболизма эритроцитарных мембран и его влияние на гемодинамику. Охарактеризована связь между нарушением липидного метаболизма, расстройством функции клеточных мембран и их последствиями, включая развитие некротических процессов в тканях. Обращается особое внимание на значение снижения содержания общего холестерина, а также холестерина липопротеинов высокой, низкой и очень низкой плотности в формировании СПОН, в частности, описываются предлагаемые пути влияния дефицита холестерина на прогрессирование органной дисфункции. Приводятся данные об изменении содержания модифицированных липопротеинов, а также фосфолипидов и триглицеридов в плазме крови при СПОН. Отмечается наличие и вероятная роль дефицита плазмалогенов плазмы крови в органных нарушениях при СПОН. Рассматривается вопрос о функционально-метаболической роли дисфункции пероксисом и митохондрий в патогенезе СПОН. Приведено обоснование важности контроля показателей липидного метаболизма при оценке тяжести состояния пациентов с наличием СПОН.</p></abstract><trans-abstract xml:lang="en"><p>The review presents data from various researchers, including the authors of this article, regarding the role of lipid metabolism disorders, as well as the causes that caused them in the formation of multiple organ dysfunction syndrome (MODS). Information is provided on the contribution of intense lipolysis in fat depots to the development of the immune response, as well as the formation of acute respiratory distress syndrome and acute kidney injury. The contribution of intense lipolysis to the process of changing the composition of fatty acids in blood plasma is characterized. The importance of intensifying the oxidative metabolism of arachidonic acid in the blood in the development of circulatory disorders and the occurrence of systemic inflammation is shown. Changes in lipid metabolism of erythrocyte membranes and its effect on hemodynamics are described. The relevance between disorders of lipid metabolism, dysfunction of cell membranes and their consequences, including the development of necrotic processes in tissues, has been characterized. Particular attention is paid to the importance of reducing the content of total cholesterol, as well as high-, low- and very low-density lipoprotein cholesterol in the formation of MODS, in particular, the proposed ways of influencing cholesterol deficiency on the progression of organ dysfunction are described. Data are provided on changes in the content of modified lipoproteins, as well as phospholipids and triglycerides in the blood plasma during MODS. The presence and probable role of plasma plasmalogen deficiency in organ disorders in MODS is noted. The problem of functional and metabolic role of peroxisome and mitochondria dysfunction in the pathogenesis of MODS is considered. The rationale for the importance of monitoring lipid metabolism parameters when assessing the severity of the condition of patients with MODS is provided.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>липиды</kwd><kwd>метаболизм</kwd><kwd>синдром полиорганной недостаточности</kwd><kwd>сепсис</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lipids</kwd><kwd>metabolism</kwd><kwd>multiple organ dysfunction syndrome</kwd><kwd>sepsis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Алимова Х.П., Алибекова М.Б. Полиорганная недостаточность: проблемы и современные методы лечения. Вестник экстренной медицины. 2019;12(1):75-80.</mixed-citation><mixed-citation xml:lang="en">Alimova HP, Alibekova MB. Multiple organ failure: problems and modern methods of treatment. The Bulletin of Emergency Medicine. 2019;12(1):75-80. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Семенов В.М., Щастный А.Т., Горбачев В.В., Дмитраченко Т.И., Мартов В.Ю., Егоров С.К. и др. Сепсис: пособие. Витебск: ВГМУ, 2020.</mixed-citation><mixed-citation xml:lang="en">Semenov VM, Shchastny AT, Gorbachev VV, Dmitrachenko TI, Martov VY, Egorov SK, et al. Sepsis: a manual. Vitebsk: VSMU, 2020. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Точило С.А. Предикторы развития синдрома полиорганной дисфункции у пациентов после абдоминальных хирургических вмешательств. Новости хирургии. 2017;25(5):494-502.</mixed-citation><mixed-citation xml:lang="en">Tachyla SA. Predictors for the development of multiple organ dysfunction syndrome in patients after abdominal surgery. Novosti Khirurgii. 2017;25(5):494-502. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Das UN. Infection, Inflammation, and Immunity in Sepsis. Biomolecules. 2023;13(9):1332. DOI: https://doi.org/10.3390/biom13091332</mixed-citation><mixed-citation xml:lang="en">Das UN. Infection, Inflammation, and Immunity in Sepsis. Biomolecules. 2023;13(9):1332. DOI: https://doi.org/10.3390/biom13091332</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Илюкевич Г.В., Канус И.И., Хулуп Г.Я. Особенности нарушения метаболизма липидов и возможность их коррекции у больных с распространенным перитонитом. Вестник интенсивной терапии. 2002;(3):83-87.</mixed-citation><mixed-citation xml:lang="en">Ilyukevich GV, Kanus II, Khulup GY. Features of lipid metabolism disorders and the possibility of their correction in patients with widespread peritonitis. Annals of Critical Care. 2002;(3):83- 87. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Власов А.П., Трофимов В.А., Аширов Р.З. Роль нарушений липидного гомеостаза в патогенезе перитонита. Саранск: Изд-во Мордов. ун-та, 2000.</mixed-citation><mixed-citation xml:lang="en">Vlasov AP, Trofimov VA, Ashirov RZ. The role of lipid homeostasis disorders in the pathogenesis of peritonitis. Saransk: Mordovian University Publishing House, 2000. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wasyluk W, Zwolak A. Metabolic Alterations in Sepsis. J Clin Med. 2021;10(11):2412. DOI: https://doi.org/10.3390/jcm10112412</mixed-citation><mixed-citation xml:lang="en">Wasyluk W, Zwolak A. Metabolic Alterations in Sepsis. J Clin Med. 2021;10(11):2412. DOI: https://doi.org/10.3390/jcm10112412</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kozlov AV, Grillari J. Pathogenesis of Multiple Organ Failure: The Impact of Systemic Damage to Plasma Membranes. Front Med (Lausanne). 2022;9:806462. DOI: https://doi.org/10.3389/fmed.2022.806462</mixed-citation><mixed-citation xml:lang="en">Kozlov AV, Grillari J. Pathogenesis of Multiple Organ Failure: The Impact of Systemic Damage to Plasma Membranes. Front Med (Lausanne). 2022;9:806462. DOI: https://doi.org/10.3389/fmed.2022.806462</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Arabi YM, Tamimi W, Jones G, Jawdat D, Tamim H, AlDorzi HM, et al. Free Fatty Acids’ Level and Nutrition in Critically Ill Patients and Association with Outcomes: A Prospective SubStudy of PermiT Trial. Nutrients. 2019;11(2):384. DOI: https://doi.org/10.3390/nu11020384</mixed-citation><mixed-citation xml:lang="en">Arabi YM, Tamimi W, Jones G, Jawdat D, Tamim H, AlDorzi HM, et al. Free Fatty Acids’ Level and Nutrition in Critically Ill Patients and Association with Outcomes: A Prospective SubStudy of PermiT Trial. Nutrients. 2019;11(2):384. DOI: https://doi.org/10.3390/nu11020384</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Osipenko AN, Marochkov AV. Blood plasma plasmalogens and fatty acids in multiple organ dysfunction syndrome. Crit Care Shock. 2017;20(2):40-45.</mixed-citation><mixed-citation xml:lang="en">Osipenko AN, Marochkov AV. Blood plasma plasmalogens and fatty acids in multiple organ dysfunction syndrome. Crit Care Shock. 2017;20(2):40-45.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tachyla S, Osipenko A, Tupitsyna O. Assessment of lipolysis activity by the composition of plasma fatty acids. Intensive Care Medicine Experimental. 2020;8(Suppl. 2):321-322.</mixed-citation><mixed-citation xml:lang="en">Tachyla S, Osipenko A, Tupitsyna O. Assessment of lipolysis activity by the composition of plasma fatty acids. Intensive Care Medicine Experimental. 2020;8(Suppl. 2):321-322.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Osipenko AN, Orlov DA, Akulich NV. Changes in the fatty acid composition under conditions of polyneuropathy related to type 1 diabetes mellitus. Neurophysiology. 2012;44(6):487-489. DOI: https://doi.org/10.1007/s11062-012-9323-8</mixed-citation><mixed-citation xml:lang="en">Osipenko AN, Orlov DA, Akulich NV. Changes in the fatty acid composition under conditions of polyneuropathy related to type 1 diabetes mellitus. Neurophysiology. 2012;44(6):487-489. DOI: https://doi.org/10.1007/s11062-012-9323-8</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Christofides A, Konstantinidou E, Jani C, Boussiotis VA. The role of peroxisome proliferator-activated receptors (PPAR) in immune responses. Metabolism. 2021;114:154338. DOI: https://doi.org/10.1016/j.metabol.2020.154338</mixed-citation><mixed-citation xml:lang="en">Christofides A, Konstantinidou E, Jani C, Boussiotis VA. The role of peroxisome proliferator-activated receptors (PPAR) in immune responses. Metabolism. 2021;114:154338. DOI: https://doi.org/10.1016/j.metabol.2020.154338</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hosseinzadeh A, Moogooei M, Mostafaei S, Rahavi H, Mansouri R, Soukhtehzari S, et al. Fatty Acids Effect on T Helper Differentiation in Vitro. International Journal of Food Sciences and Nutrition. 2016; 5(5-6):372-377. DOI: https://doi.org/10.11648/j.ijnfs.20160506.11</mixed-citation><mixed-citation xml:lang="en">Hosseinzadeh A, Moogooei M, Mostafaei S, Rahavi H, Mansouri R, Soukhtehzari S, et al. Fatty Acids Effect on T Helper Differentiation in Vitro. International Journal of Food Sciences and Nutrition. 2016; 5(5-6):372-377. DOI: https://doi.org/10.11648/j.ijnfs.20160506.11</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Masi LN, Rodrigues AC, Curi R. Fatty acids regulation of inflammatory and metabolic genes. Curr Opin Clin Nutr Metab Care. 2013;16(4):418-424. DOI: https://doi.org/10.1097/MCO.0b013e32836236df</mixed-citation><mixed-citation xml:lang="en">Masi LN, Rodrigues AC, Curi R. Fatty acids regulation of inflammatory and metabolic genes. Curr Opin Clin Nutr Metab Care. 2013;16(4):418-424. DOI: https://doi.org/10.1097/MCO.0b013e32836236df</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol. 2010;85(6):1629-1642. DOI: https://doi.org/10.1007/s00253-009-2355-3</mixed-citation><mixed-citation xml:lang="en">Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol. 2010;85(6):1629-1642. DOI: https://doi.org/10.1007/s00253-009-2355-3</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Saitta F, Motta P, Barbiroli A, Signorelli M, La Rosa C, Janaszewska A, et al. Influence of Free Fatty Acids on Lipid Membrane-Nisin Interaction. Langmuir. 2020;36(45):13535-13544. DOI: https://doi.org/10.1021/acs.langmuir.0c02266</mixed-citation><mixed-citation xml:lang="en">Saitta F, Motta P, Barbiroli A, Signorelli M, La Rosa C, Janaszewska A, et al. Influence of Free Fatty Acids on Lipid Membrane-Nisin Interaction. Langmuir. 2020;36(45):13535-13544. DOI: https://doi.org/10.1021/acs.langmuir.0c02266</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, et al. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int. 2002;62(5):1628-1637. DOI: https://doi.org/10.1046/j.1523-1755.2002.00618.x</mixed-citation><mixed-citation xml:lang="en">Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, et al. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int. 2002;62(5):1628-1637. DOI: https://doi.org/10.1046/j.1523-1755.2002.00618.x</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kaduce TL, Spector AA, Bar RS. Linoleic acid metabolism and prostaglandin production by cultured bovine pulmonary artery endothelial cells. Arteriosclerosis. 1982;2(5):380-9. DOI: https://doi.org/10.1161/01.atv.2.5.380</mixed-citation><mixed-citation xml:lang="en">Kaduce TL, Spector AA, Bar RS. Linoleic acid metabolism and prostaglandin production by cultured bovine pulmonary artery endothelial cells. Arteriosclerosis. 1982;2(5):380-9. DOI: https://doi.org/10.1161/01.atv.2.5.380</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Орлов Ю.П. Внутрисосудистый гемолиз эритроцитов в развитии органных дисфункций при критических состояниях. Общая реаниматология. 2008;4(2):88-93. DOI: https://doi.org/10.15360/1813-9779-2008-2-88</mixed-citation><mixed-citation xml:lang="en">Orlov YI. Intravascular hemolysis of red blood cells in the development of organ dysfunctions in critical conditions. General Reanimatology. 2008;4(2):88-93. (In Russ.). DOI: https://doi.org/10.15360/1813-9779-2008-2-88</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Dinkla S, van Eijk LT, Fuchs B, Schiller J, Joosten I, Brock R, et al. Inflammation-associated changes in lipid composition and the organization of the erythrocyte membrane. BBA Clin. 2016;5:186-92. DOI: https://doi.org/10.1016/j.bbacli.2016.03.007</mixed-citation><mixed-citation xml:lang="en">Dinkla S, van Eijk LT, Fuchs B, Schiller J, Joosten I, Brock R, et al. Inflammation-associated changes in lipid composition and the organization of the erythrocyte membrane. BBA Clin. 2016;5:186-92. DOI: https://doi.org/10.1016/j.bbacli.2016.03.007</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Osipenko A. Fatty acid composition of erythrocytes and blood plasma in multiple organ dysfunction syndrome. American Journal of Bioscience and Bioengineering. 2015;3(5):114-117. DOI: https://doi.org/10.11648/j.bio.20150305.25</mixed-citation><mixed-citation xml:lang="en">Osipenko A. Fatty acid composition of erythrocytes and blood plasma in multiple organ dysfunction syndrome. American Journal of Bioscience and Bioengineering. 2015;3(5):114-117. DOI: https://doi.org/10.11648/j.bio.20150305.25</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS, et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol. 2007;27(2):414-421. DOI: https://doi.org/10.1161/01.ATV.0000252898.48084.6a</mixed-citation><mixed-citation xml:lang="en">Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS, et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol. 2007;27(2):414-421. DOI: https://doi.org/10.1161/01.ATV.0000252898.48084.6a</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Di Gioia M, Poli V, Tan PJ, Spreafico R, Chu A, Cuenca AG, et al. Host-derived oxidized phospholipids initiate effectortriggered immunity fostering lethality upon microbial encounter. bioRxiv. 2023:2023.11.21.568047. DOI: https://doi.org/10.1101/2023.11.21.568047</mixed-citation><mixed-citation xml:lang="en">Di Gioia M, Poli V, Tan PJ, Spreafico R, Chu A, Cuenca AG, et al. Host-derived oxidized phospholipids initiate effectortriggered immunity fostering lethality upon microbial encounter. bioRxiv. 2023:2023.11.21.568047. DOI: https://doi.org/10.1101/2023.11.21.568047</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 2014;5(1):66-72. DOI: https://doi.org/10.4161/viru.26907</mixed-citation><mixed-citation xml:lang="en">Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 2014;5(1):66-72. DOI: https://doi.org/10.4161/viru.26907</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kitsiouli E, Tenopoulou M, Papadopoulos S, Lekka ME. Phospholipases A2 as biomarkers in acute respiratory distress syndrome. Biomed J. 2021;44(6):663-670. DOI: https://doi.org/10.1016/j.bj.2021.08.005</mixed-citation><mixed-citation xml:lang="en">Kitsiouli E, Tenopoulou M, Papadopoulos S, Lekka ME. Phospholipases A2 as biomarkers in acute respiratory distress syndrome. Biomed J. 2021;44(6):663-670. DOI: https://doi.org/10.1016/j.bj.2021.08.005</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Hofmaenner DA, Kleyman A, Press A, Bauer M, Singer M. The Many Roles of Cholesterol in Sepsis: A Review. Am J Respir Crit Care Med. 2022;205(4):388-396. DOI: https://doi.org/10.1164/rccm.202105-1197TR</mixed-citation><mixed-citation xml:lang="en">Hofmaenner DA, Kleyman A, Press A, Bauer M, Singer M. The Many Roles of Cholesterol in Sepsis: A Review. Am J Respir Crit Care Med. 2022;205(4):388-396. DOI: https://doi.org/10.1164/rccm.202105-1197TR</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Липницкий А.Л., Марочков А.В., Морозов Д.П., Акулич Н.В., Жилинский Д.А., Шваленок В.В. Прогностическая ценность уровня холестерина у больных в критическом состоянии. Здравоохранение. 2012;(1):8-11.</mixed-citation><mixed-citation xml:lang="en">Lipnitsky AL, Marochkov AV, Morozov DP, Akulich NV, Zhilinsky DA, Shvalenok VV. Prognostic value of cholesterol levels in critically ill patients. Healthcare. 2012;(1):8-11. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Точило С.А., Марочков А.В., Ливинская В.А., Кизименко А.Н., Никитина Е.В. Прогностическая значимость различных биомаркеров в отношении синдрома полиорганной недостаточности у пациентов в абдоминальной хирургии. Біль, знеболення та інтенсивна терапія. 2020;91(2):87-96. DOI: https://doi.org/10.25284/2519-2078.2(91).2020.205604</mixed-citation><mixed-citation xml:lang="en">Tachyla SA, Marochkov AV, Livinskaya VA, Kizimenko AN, Nikitina EV. Prognostic value of various biomarkers for sepsis and multiple organ dysfunction syndrome in abdominal surgery patients. Pain, anesthesia and intensive care. 2020;91(2):87-96. (In Russ.). DOI: https://doi.org/10.25284/2519-2078.2(91).2020.205604</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Fraunberger P, Nagel D, Walli AK, Seidel D. Serum cholesterol and mortality in patients with multiple organ failure. Crit Care Med. 2000;28(10):3574-3575. DOI: https://doi.org/10.1097/00003246-200010000-00047</mixed-citation><mixed-citation xml:lang="en">Fraunberger P, Nagel D, Walli AK, Seidel D. Serum cholesterol and mortality in patients with multiple organ failure. Crit Care Med. 2000;28(10):3574-3575. DOI: https://doi.org/10.1097/00003246-200010000-00047</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Cirstea M, Walley KR, Russell JA, Brunham LR, Genga KR, Boyd JH. Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis. J Crit Care. 2017;38:289-294. DOI: https://doi.org/10.1016/j.jcrc.2016.11.041</mixed-citation><mixed-citation xml:lang="en">Cirstea M, Walley KR, Russell JA, Brunham LR, Genga KR, Boyd JH. Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis. J Crit Care. 2017;38:289-294. DOI: https://doi.org/10.1016/j.jcrc.2016.11.041</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Мальцева Л.А., Мосенцев Н.Ф., Лисничая В.Н., Левчук А.А. Кортикостероидная недостаточность при критических состояниях у взрослых пациентов. Медицина неотложных состояний. 2018;91(4):45-50. DOI: https://doi.org/10.22141/2224-0586.4.91.2018.137855</mixed-citation><mixed-citation xml:lang="en">Maltseva LA, Mosentsev NF, Lisnichaya VN, Levchuk AA. Corticosteroid deficiency in critically ill adults. Emergency medicine. 2018;91(4):45-50. (In Russ.). DOI: https://doi.org/10.22141/2224-0586.4.91.2018.137855</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Осипенко А.Н., Марочков А.В., Акулич Н.В. Дисфункция пероксисом как одна из возможных причин развития синдрома полиорганной недостаточности. Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук. 2012;86(4-2):96-100.</mixed-citation><mixed-citation xml:lang="en">Osipenko AN, Marochkov AV, Akulich NV. Dysfunction of peroxisomes as one of possible causes of development of multiple organ dysfunction syndrome. Acta Biomedica Scientifica. 2012;(4-2):96-100. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Braverman NE, Moser AB. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta. 2012;1822(9):1442-1452. DOI: https://doi.org/10.1016/j.bbadis.2012.05.008</mixed-citation><mixed-citation xml:lang="en">Braverman NE, Moser AB. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta. 2012;1822(9):1442-1452. DOI: https://doi.org/10.1016/j.bbadis.2012.05.008</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Галочкин В.А., Агафонова А.В., Галочкина В.П., Черепанов Г.Г. Метаболические и регуляторные функции пероксисом (обзор). Проблемы биологии продуктивных животных. 2015;(1):5-24.</mixed-citation><mixed-citation xml:lang="en">Galochkin VA, Agafonova AV, Galochkina VP, Cherepanov GG. Metabolic and regulatory functions of peroxisomes (review). Problems of biology of productive animals. 2015;(1):5-24. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Di Cara F, Andreoletti P, Trompier D, Vejux A, Bülow MH, Sellin J, et al. Peroxisomes in Immune Response and Inflammation. Int J Mol Sci. 2019;20(16):3877. DOI: https://doi.org/10.3390/ijms20163877</mixed-citation><mixed-citation xml:lang="en">Di Cara F, Andreoletti P, Trompier D, Vejux A, Bülow MH, Sellin J, et al. Peroxisomes in Immune Response and Inflammation. Int J Mol Sci. 2019;20(16):3877. DOI: https://doi.org/10.3390/ijms20163877</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Bozelli JC, Azher S, Epand R M. Plasmalogens and Chronic Inflammatory Diseases. Frontiers in Physiology. 2021;12:730829. DOI: https://doi.org/10.3389/fphys.2021.730829</mixed-citation><mixed-citation xml:lang="en">Bozelli JC, Azher S, Epand R M. Plasmalogens and Chronic Inflammatory Diseases. Frontiers in Physiology. 2021;12:730829. DOI: https://doi.org/10.3389/fphys.2021.730829</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Charles KN, Shackelford JE, Faust PL, Fliesler SJ, Stangl H, Kovacs WJ. Functional Peroxisomes Are Essential for Efficient Cholesterol Sensing and Synthesis. Front Cell Dev Biol. 2020;8:560266. DOI: https://doi.org/10.3389/fcell.2020.560266</mixed-citation><mixed-citation xml:lang="en">Charles KN, Shackelford JE, Faust PL, Fliesler SJ, Stangl H, Kovacs WJ. Functional Peroxisomes Are Essential for Efficient Cholesterol Sensing and Synthesis. Front Cell Dev Biol. 2020;8:560266. DOI: https://doi.org/10.3389/fcell.2020.560266</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Schrader M, Fahimi HD. Peroxisomes and oxidative stress. Biochim Biophys Acta. 2006;1763:1755-1766.</mixed-citation><mixed-citation xml:lang="en">Schrader M, Fahimi HD. Peroxisomes and oxidative stress. Biochim Biophys Acta. 2006;1763:1755-1766.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp Mol Med. 2004;36(1):1-12. DOI: https://doi.org/10.1038/emm.2004.1</mixed-citation><mixed-citation xml:lang="en">Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp Mol Med. 2004;36(1):1-12. DOI: https://doi.org/10.1038/emm.2004.1</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
